NO137387C - Analogifremgangsm}te til fremstilling av 5-metyltiopyrimidiner med terapeutisk virkning - Google Patents

Analogifremgangsm}te til fremstilling av 5-metyltiopyrimidiner med terapeutisk virkning

Info

Publication number
NO137387C
NO137387C NO3261/73A NO326173A NO137387C NO 137387 C NO137387 C NO 137387C NO 3261/73 A NO3261/73 A NO 3261/73A NO 326173 A NO326173 A NO 326173A NO 137387 C NO137387 C NO 137387C
Authority
NO
Norway
Prior art keywords
methyltiopyrimidines
preparation
therapeutic effect
analogical procedure
analogical
Prior art date
Application number
NO3261/73A
Other languages
English (en)
Norwegian (no)
Other versions
NO326173L (ja
NO137387B (no
Inventor
Jean-Marie Claverie
Gerard Loiseau
Georges Mattioda
Rene Millischer
Francois Percheron
Original Assignee
Ugine Kuhlmann
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ugine Kuhlmann filed Critical Ugine Kuhlmann
Publication of NO326173L publication Critical patent/NO326173L/no
Publication of NO137387B publication Critical patent/NO137387B/no
Publication of NO137387C publication Critical patent/NO137387C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO3261/73A 1973-07-06 1973-08-16 Analogifremgangsm}te til fremstilling av 5-metyltiopyrimidiner med terapeutisk virkning NO137387C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7324875A FR2244520B1 (ja) 1973-07-06 1973-07-06

Publications (3)

Publication Number Publication Date
NO326173L NO326173L (ja) 1975-02-03
NO137387B NO137387B (no) 1977-11-14
NO137387C true NO137387C (no) 1978-02-22

Family

ID=9122192

Family Applications (1)

Application Number Title Priority Date Filing Date
NO3261/73A NO137387C (no) 1973-07-06 1973-08-16 Analogifremgangsm}te til fremstilling av 5-metyltiopyrimidiner med terapeutisk virkning

Country Status (11)

Country Link
US (1) US3968214A (ja)
JP (1) JPS5025576A (ja)
BE (1) BE803804A (ja)
CH (1) CH581120A5 (ja)
DE (1) DE2342881A1 (ja)
ES (1) ES418114A1 (ja)
FR (1) FR2244520B1 (ja)
GB (1) GB1450211A (ja)
LU (1) LU68264A1 (ja)
NL (1) NL7312324A (ja)
NO (1) NO137387C (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2417507A2 (fr) * 1977-07-28 1979-09-14 Ugine Kuhlmann Diamino-2,4 (ou -4,6) methylthio-5 pyrimidines herbicides
US4560402A (en) * 1979-08-15 1985-12-24 Ciba Geigy Corporation 2,4-Diamo-5-(alkylsulfinyl) or alkylsulphonyl)-6-halopyrimidines
FR2503162A1 (fr) * 1981-04-07 1982-10-08 Pharmindustrie Nouveaux derives de piperazino-2 pyrimidine, procedes pour leur preparation et leur utilisation comme medicaments ou comme intermediaires pour la fabrication de medicaments
DE3417264A1 (de) * 1984-05-10 1985-11-14 Bayer Ag, 5090 Leverkusen Neue 2,4-diamino-6-halogen-5-alkylthio-pyrimidine
US5002949A (en) * 1990-05-01 1991-03-26 American Home Products Corporation 5-substituted-6-aminopyrimidine derivatives
US7205320B2 (en) * 2001-01-22 2007-04-17 Memory Pharmaceuticals Corp. Phosphodiesterase 4 inhibitors
CA2492911A1 (en) 2002-07-19 2004-01-29 Memory Pharmaceuticals Corporation 6-amino-1h-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors
WO2004052862A1 (ja) 2002-12-10 2004-06-24 Ono Pharmaceutical Co., Ltd. 含窒素複素環化合物およびその医薬用途
WO2006135828A2 (en) * 2005-06-10 2006-12-21 Memory Pharmaceuticals Corporation Trisubstituted amines as phosphodiesterase 4 inhibitors
MX2008016007A (es) 2006-06-15 2009-01-16 Boehringer Ingelheim Int 2-anilino-4-aminoalquilenoaminopirimidinas.
EP2054392A2 (en) 2006-06-15 2009-05-06 Boehringer Ingelheim International GmbH 2-anilino-4-(heterocyclic)amino-pyrimidines as inhibitors of protein kinase c-alpha
US20100029689A1 (en) * 2008-07-02 2010-02-04 Memory Pharmaceuticals Corporation Phosphodiesterase 4 inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3817998A (en) * 1971-10-28 1974-06-18 Sandoz Ag 2-amino and substituted amino-4, 6-diamino-5-pyrimidinesulfonamides

Also Published As

Publication number Publication date
DE2342881A1 (de) 1975-01-30
CH581120A5 (ja) 1976-10-29
NO326173L (ja) 1975-02-03
JPS5025576A (ja) 1975-03-18
FR2244520A1 (ja) 1975-04-18
NL7312324A (nl) 1975-01-08
LU68264A1 (ja) 1973-10-24
US3968214A (en) 1976-07-06
ES418114A1 (es) 1976-03-16
NO137387B (no) 1977-11-14
FR2244520B1 (ja) 1977-02-04
GB1450211A (en) 1976-09-22
BE803804A (fr) 1974-02-20

Similar Documents

Publication Publication Date Title
SE423631B (sv) Forfarande for framstellning av oxaalhyl-dialkylxantiner
NO138374C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 4-fenoksyfenoksyalkankarboksylsyrederivater
SE7710599L (sv) Forfarande for framstellning av bensisoxazoler
SE406197B (sv) Analogiforfarande for framstellning av 4-aminokinazolinderivat
FI55846B (fi) Foerfarande foer framstaellning av 8-azapurin-5-onderivat med terapeutisk anvaendning
NO740606L (no) Analogifremgangsmåte til fremstilling av terapeutisk virksomme 3-klor-7-alfa-amino-acylcefalosporinforbindelser.
NO137387C (no) Analogifremgangsm}te til fremstilling av 5-metyltiopyrimidiner med terapeutisk virkning
NO146596C (no) Fremgangsmaate for fremstilling av 6-deoksytetracykliner
SE417601B (sv) Forfarande for framstellning av amidinokarbamider
NO790627L (no) Fremgangsmaate for fremstilling av hydroksyalkylxantiner
SE399263B (sv) Analogiforfarande for framstellning av triazaspirodekaner med terapeutisk verkan
SE409716B (sv) Analogiforfarande for framstellning av 11beta-alkyl-deltaŸ4-estrener
NO843825L (no) Fremgangsmaate for fremstilling av 6-deoksytetracyklin
NO136795C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive indoliner
SE7607717L (sv) Analogiforfarande for framstellning av l-pyroglutamyl-l-prolinamid
SE399069B (sv) Analogiforfarande for framstellning av triazolo-pyridino-isokinolin-derivat
SE426582B (sv) Forfarande for framstellning av foreningar med kolesterolsenkande effekt
NO138561C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme cykloalkylfenoksykarboksylsyrederivater
SE410596B (sv) Analogiforfarande for framstellning av bensoyl-fenylalanyl-tyrosinderivat med terapeutisk verkan
NO137205C (no) Analogifremgangsm}te for fremstilling av piperazinpyrimidiner med terapeutisk virkning.
NO740607L (no) Analogifremgangsmåte til fremstilling av terapeutisk virksomme 7-acylamino-3-halogen-cefalosporinforbindelser.
NO137752C (no) Analogifremgangsmaater til fremstilling av forbindelser med antiarrytmisk virkning
SE409994B (sv) Forfarande for framstellning av amidinokarbamider
NO140104C (no) Analogifremgangsmaate til fremstilling av 17beta-hydroksy-16,16-dimetylestr-4-en-3-on med terapeutisk aktivitet
NO139125C (no) Analogifremgangsmaate for fremstilling av cykloheksantetrolderivater

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees